236 related articles for article (PubMed ID: 3906674)
1. The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
Verho M; Bückert C; Freude J; Jaeger S; Pahnke K
Pharmatherapeutica; 1985; 4(5):288-95. PubMed ID: 3906674
[TBL] [Abstract][Full Text] [Related]
2. [Diuretic monotherapy in heart failure. Comparison of piretanide and hydrochlorothiazide-triamterene].
Gonska BD; Kreuzer H
Dtsch Med Wochenschr; 1985 Nov; 110(47):1812-6. PubMed ID: 3905326
[TBL] [Abstract][Full Text] [Related]
3. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.
Verho M; Rangoonwala B; Dols W; Fratzer U; Kaczynski J; Mühlhäusler W
Eur J Clin Pharmacol; 1984; 27(4):407-14. PubMed ID: 6394349
[TBL] [Abstract][Full Text] [Related]
4. Piretanide in the treatment of essential hypertension. A double-blind comparison versus placebo.
Verho M; Rangoonwala B; Beloso M; Maass L; Bender R; Garduno D
Drugs Exp Clin Res; 1986; 12(5):385-91. PubMed ID: 3522159
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of piretanide (a potassium-stable diuretic) on serum magnesium.
Verho M; Irmisch R; de Looze S; Rangoonwala B
Int J Clin Pharmacol Res; 1987; 7(6):433-42. PubMed ID: 3440634
[TBL] [Abstract][Full Text] [Related]
6. Serum selenium levels in diuretic-treated hypertensives: a double-blind trial of piretanide against hydrochlorothiazide plus amiloride.
Verho M; Bossaller W; Malerczyk V
Int J Clin Pharmacol Res; 1988; 8(1):5-8. PubMed ID: 3284831
[TBL] [Abstract][Full Text] [Related]
7. Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride.
Verho M; Bossaller W; Heinen B
Int J Clin Pharmacol Res; 1987; 7(1):5-11. PubMed ID: 3294616
[TBL] [Abstract][Full Text] [Related]
8. Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
McNabb WR; Noormohamed FH; Lant AF
Br J Clin Pharmacol; 1988 Aug; 26(2):143-54. PubMed ID: 3207551
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of penbutolol and a combination of a low dose of penbutolol with piretanide in the treatment of mild to moderate hypertension.
Graml E; Verho M; Rangoonwala B; Englert R; Häringer E; Pahnke K
Pharmatherapeutica; 1985; 4(4):236-43. PubMed ID: 3903788
[TBL] [Abstract][Full Text] [Related]
10. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
11. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
McClennen W; Wilson T
Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of penbutolol + piretanide combinations in the treatment of arterial hypertension.
Verho M; Rangoonwala B; Pahnke K; Freude J; Häringer E
Drugs Exp Clin Res; 1985; 11(10):717-23. PubMed ID: 3915460
[TBL] [Abstract][Full Text] [Related]
13. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension: a double-blind comparison of two formulations.
Dols W; Verho M; Rangoonwala B; Jaeger S
J Int Med Res; 1985; 13(1):31-9. PubMed ID: 3884409
[TBL] [Abstract][Full Text] [Related]
14. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
Verho M; Kirsten R; Bückert C
Pharmatherapeutica; 1984; 3(9):595-606. PubMed ID: 6374680
[TBL] [Abstract][Full Text] [Related]
15. The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.
Meywald W; Maass L; Verho M; Rangoonwala B
Pharmatherapeutica; 1985; 4(6):356-66. PubMed ID: 4080753
[TBL] [Abstract][Full Text] [Related]
16. The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide.
Car N; Skrabalo Z; Verho M
Curr Med Res Opin; 1988; 11(2):133-41. PubMed ID: 3219881
[TBL] [Abstract][Full Text] [Related]
17. Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure.
Sherman LG; Liang CS; Baumgardner S; Charuzi Y; Chardo F; Kim CS
Clin Pharmacol Ther; 1986 Nov; 40(5):587-94. PubMed ID: 3533372
[TBL] [Abstract][Full Text] [Related]
18. Safety of concomitant potassium-sparing diuretics in angiotensin-converting enzyme inhibitor therapy in severe congestive heart failure. Xamoterol in Severe Heart Failure Study Group.
Bergler-Klein J; Sochor H; Pouleur H; Pacher R; Porenta G; Glogar D
J Cardiovasc Pharmacol; 1994 Aug; 24(2):194-8. PubMed ID: 7526050
[TBL] [Abstract][Full Text] [Related]
19. [Effects of potassium chloride and triamterene on kaliuresis, natriuresis and diuresis in congestive heart failure].
Kabakov AI; Zharov EI
Klin Med (Mosk); 1995; 73(5):33-5. PubMed ID: 8815272
[TBL] [Abstract][Full Text] [Related]
20. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Gheorghiade M; Niazi I; Ouyang J; Czerwiec F; Kambayashi J; Zampino M; Orlandi C;
Circulation; 2003 Jun; 107(21):2690-6. PubMed ID: 12742979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
